• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Second Sight

Second Sight Medical, Nano Precision Medical merging to create therapeutic implant company

February 8, 2022 By Sean Whooley

Second Sight Medical Products (NSDQ:EYES) and Nano Precision Medical agreed to a merger deal that will result in a focus on drug-device medical implants. The two companies entered into a definitive agreement under which privately held Nano Precision Medical (NPM) will merge with a wholly-owned subsidiary of Second Sight in an all-stock transaction, with NPM […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Implants, Mergers & Acquisitions, Pharmaceutical Tagged With: Nano Precision Medical, Second Sight

MedTech 100 roundup: Nearing new highs once again

June 28, 2021 By Sean Whooley

Having hit a downturn as the summer neared, the medtech industry is now consistently on the rise as June comes to a close. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 25) at 113.42 points, producing a 2.5% rise from the 110.64-point mark set […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Mergers & Acquisitions, Wall Street Beat Tagged With: Bigfoot Biomedical, Boston Scientific, coronavirus, COVID-19, Indago, Integra LifeSciences, Lazurite, MedTech 100 Index, Medtronic, Minnetronix Medical, Pear Therapeutics, Philips, Quanta Dialysis Technologies, Second Sight, Smith+Nephew, Vicarious Surgical

Second Sight Medical plans to raise $50 million from public offering

June 23, 2021 By Sean Whooley

Second Sight Medical Products announced that it plans to offer shares of its common stock in a public offering worth $50 million. Los Angeles–based Second Sight priced the underwritten public offering of 10 million shares of common stock at a public offering price of $5 per share to yield gross proceeds of $50 million, according […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Optical/Ophthalmic Tagged With: Second Sight

MedTech 100 roundup: Industry roars back

April 12, 2021 By Sean Whooley

In the blink of an eye, the medtech industry exited its spring slump and neared its all-time best performance levels. MassDevice‘s MedTech 100 Index offered signs of a rebound last week and has built on that momentum, registering a final tally of 109.39 points on April 9. That represents a 2.9% increase from the 106.26-point mark […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Better Therapeutics, Google, Hologic, INSIGHTEC, LumiraDX, MedTech 100 Index, Medtronic, Olympus, Outset Medical, Pixium Vision, Second Sight, Varian

Second Sight, Pixium Vision merger plans are over

April 5, 2021 By Sean Whooley

Second Sight Medical notified Pixium that it decided to unilaterally terminate a memorandum of understanding (MOU) ahead of a planned merger. In a news release, Pixium said the $27.9 million private placement recently announced and closed by Second Sight was “not only explicitly prohibited under the terms of the [MOU] entered into by the companies […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Optical/Ophthalmic Tagged With: Pixium Vision, Second Sight

Second Sight names acting CEO

April 1, 2021 By Sean Whooley

Second Sight Medical (NSDQ:EYES) announced today that it has named a new acting chief executive officer. Los Angeles-based Second Sight said in a news release that Scott Dunbar has been named by its board of directors to replace Matthew Pfeffer as acting CEO. Under Nasdaq rules, an independent director may temporarily be named acting CEO […]

Filed Under: Business/Financial News, Featured, Implants, Optical/Ophthalmic Tagged With: Personnel Moves, Second Sight

MedTech 100 roundup: Slight rise for the industry

March 29, 2021 By Sean Whooley

While medtech’s performance still isn’t mirroring the beginning of 2021, the industry is showing signs of life with a small improvement last week. The year’s strong start, during which MassDevice‘s MedTech 100 index notched an all-time best of 110.96 points (Feb. 15) came to an end later that month and carried over into March, with the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Mergers & Acquisitions, Wall Street Beat Tagged With: 7D Surgical, Biocorp, Boston Scientific, coronavirus, COVID-19, Decision Diagnostics, Dexcom, Diabeloop, MedTech 100 Index, Personnel Moves, Pixium Vision, SeaSpine, Second Sight

DTW Podcast – CEO MacMillan on how COVID-19 strengthened Hologic

March 27, 2021 By Tom Salemi

Hologic CEO Steve MacMillan says in early March 2020 he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to the challenge, becoming one of the surer suppliers of diagnostic tests needed to chart the coronavirus’s severity. In this DeviceTalks Weekly podcast, MacMillan shares how Hologic pivoted to meet […]

Filed Under: Device Talks Podcasts, Diagnostics, Featured, Special Content Tagged With: Boston Scientific, DeviceTalks Weekly, GuardianLane, Hologic, Medtech Color, Medtronic, Packworld USA, Pixium Vision, Second Sight, Thermo Fisher Scientific

Second Sight’s merger with Pixium Vision may fall through

March 24, 2021 By Chris Newmarker

Second Sight‘s plans to raise $27.9 million from a private placement appear to have generated conflict with its would-be owner Pixium Vision. Pixium informed Second Sight (NSDQ: EYES)  yesterday that the private placement would breach the memorandum of understanding the two companies reached in early January, according to a Second Sight filing with the SEC. […]

Filed Under: Business/Financial News, Featured, Legal News, Mergers & Acquisitions, Neuromodulation/Neurostimulation, Optical/Ophthalmic Tagged With: Pixium Vision, Second Sight

Second Sight gains FDA nod for retinal system that may never be produced

March 5, 2021 By Nancy Crotti

Second Sight Medical  (NSDQ: EYES) today announced that the FDA has approved its Argus 2s retinal prosthesis system, but questions remain about whether it will ever be manufactured. The past year has been tough for Second Sight. The company announced in March 2020 that it would wind down its operations amid the financial shock of […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Implants, Neuromodulation/Neurostimulation, Optical/Ophthalmic, Regulatory/Compliance Tagged With: FDA, Pixium Vision, Second Sight, second-sight-medical

Second Sight facing Nasdaq delisting

October 5, 2020 By Sean Whooley

Second Sight Medical (NSDQ:EYES) announced that it received a letter from the Nasdaq market confirming that it may face delisting. The Sylmar, Calif.-based developer and manufacturer of implantable visual prosthetics for blind individuals received the letter confirming that its common stock had closed below the $1 per share minimum required for continued listing for 30 consecutive […]

Filed Under: Business/Financial News, Optical/Ophthalmic, Wall Street Beat Tagged With: NASDAQ, Second Sight

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS